Shopping Cart
- Remove All
- Your shopping cart is currently empty
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1, thereby selectively inhibiting the PD-L1/PD-1 interaction, which confers its antitumor activity [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1, thereby selectively inhibiting the PD-L1/PD-1 interaction, which confers its antitumor activity [1]. |
Cas No. | 2342597-81-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.